Diabetes Care, Vol 4, Issue 6 601-605, Copyright © 1981 by American Diabetes Association
A prospective study of symptomatic hypoglycemia in young diabetic patients
DE Goldstein, JD England, R Hess, SS Rawlings and B Walker
The frequency of symptomatic hypoglycemia was determined prospectively over
an 18-mo period in 147 children and adolescents with diabetes mellitus. All
patients were treated with two daily injections of insulin. The data were
analyzed to determine the relationship between episodes of symptomatic
hypoglycemia and blood glucose control as assessed by hemoglobin A1c
measurements. There were 542 patient visits during the study period. During
each clinic visit, patients were separated into one of four hypoglycemic
categories based on the medical history since the preceding visit. These
categories were: no reactions, mild to occasional reactions, mild to
frequent reactions, and severe reactions. Reactions were considered severe
if they were characterized by altered central nervous system function or
prolonged sympathetic nervous system symptoms. Forty-seven percent of the
patients reported at least one reaction during the 18-mo study period, but
only 4% (i.e., 6 out of 147 patients) reported severe reactions. The mean
hemoglobin A1c level was significantly lower in patients who reported
reactions than in patients who did not report reactions [hemoglobin A1c
values (x +/- SEM) = 7.78 +/- 0.1% vs. 9.48 +/- 0.1%, respectively; P less
than 0.001]. The severity of hypoglycemia was inversely related to the
degree of altered blood glucose control; episodes of frequent or severe
symptomatic hypoglycemia occurred almost exclusively in patients with
well-controlled diabetes as reflected in their near-normal hemoglobin A1c
levels. There were no significant differences in mean insulin dose/kg, age,
or duration of diabetes comparing patients in the four hypoglycemic
categories. The results indicate that the hemoglobin A1c level can be a
useful clinical guide to identify patients who are most likely to develop
serious symptomatic hypoglycemia.